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Pharmacologic and gene-based approaches to normalise excitation-contraction
coupling (ECC) in heart disease often provoke compensatory adaptations. We
proposed that such (mal)adaptation re-configures homeostatic Ca2þ signalling
network to a new state that may directly contribute to disease pathogenesis
(George et al., AJP 2012). We sought to investigate approaches that could mod-
ulate disease-linked Ca2þ release abnormalities without perturbing homeostatic
Ca2þ signalling. In this proof-of-concept study we investigated the utility of
a morpholino oligonucleotide targeted to exon1 of RyR2 (rMO) to modify
Ca2þ release in HL-1 cardiomyocyte networks. Imaging of fluorescein-
labelled MOs revealed a homogeneous time- and concentration-dependent ac-
cumulation of MO in the cytoplasm of >80% HL-1 cardiomyocytes. The effi-
cacy of rMO-mediated protein knock-down was assessed using a construct
encoding RyR2 exon 1 (bases 1-25) fused to the N-terminus of eGFP. The
use of a control MO (cMO), that has no homology to known mammalian
RNAs, and the expression of eGFP minus the RyR2 exon 1 confirmed the spec-
ificity of rMO effects. Incubation of HL-1 syncytia with rMO (24-72h, 1-10uM)
did not alter RyR2 mRNA abundance and spontaneous Ca2þ oscillations and
intercellular synchronisation of Ca2þ release remained unchanged. Despite
near-identical basal Ca2þ oscillations in rMO- and cMO-treated HL-1 popula-
tions, caffeine-evoked Ca2þ transients were modulated by rMO in a concentra-
tion- and time-dependent manner. We expanded this study to determine the
effects of rMO in human ES-derived cardiomyocytes over a longer time period
(21 days). Our data support the development of MO-based methods to modulate
discrete aspects of Ca2þ signalling in cardiac disease.
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The cardiac ryanodine receptor ion channel (RyR2) is inhibited in vitro by cal-
modulin (CaM). Simultaneous substitution of three amino acid residues in the
CaM binding domain (W3587A/L3591D/F3603A, RyR2ADA) leads to loss of
CaM inhibition at submicromolar (diastolic) and micromolar (systolic) Ca2þ
concentrations in vitro and cardiac hypertrophy and heart failure in mice. To
address whether elimination of CaM inhibition at diastolic or systolic Ca2þ
causes cardiac hypertrophy, a second mutant mouse was prepared with a single
amino acid substitution (L3591D, RyR2D) in the CaM binding domain. In sin-
gle channel measurements, RyR2D lost CaM inhibition at diastolic but not sys-
tolic Ca2þ, and lost inhibition by the small Ca2þ binding protein S100A1 at
both diastolic and systolic Ca2þ. In contrast to Ryr2ADA/ADA mice, Ryr2D/D
mice had a normal lifespan and cardiac contractility. In 6-month old Ryr2D/D
mice, heart-to-body weight ratio increased by 8% with a two-fold upregulation
of atrial natriuretic peptide mRNA levels and a 40% decrease in RyR2 content.
Differences between mutant and wild-type mice were more prominent in mice
subjected to 4 weeks pressure overload using transverse aortic constriction. The
results contrast those of Ryr2ADA/ADA mice that have an impaired cardiac con-
tractile performance and die at ~2 weeks after birth, and suggest that CaM in-
hibition of RyR2 at systolic Ca2þ is important for maintaining normal cardiac
function. Supported by NIH, AHA and NSF.
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Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a life-
threatening arrhythmia. Many congenital mutations in both the cardiac ryano-
dine receptor (RyR2) and calsequestrin (CASQ2) are known to be responsible
for this disorder. It is now well established that CPVT is caused by delayed
afterdepolarizations (DADs)-induced triggered activities, and that DADs are
caused by spontaneous sarcoplasmic reticulum (SR) Ca release during Ca
overload, a process also known as store overload induced Ca release (SOICR).
A large body of evidence indicates that CPVT-causing RyR2 and CASQ2mutations enhance the propensity for SOICR and DADs by increasing the re-
sponse of RyR2 to SR luminal Ca. Recently, Marks and colleagues reported
that a CPVT RyR2 mutation G230C increases the cytosolic Ca sensitivity
(only after PKA phosphorylation) of single RyR2 channels in lipid bilayers,
but has no effect on the luminal Ca sensitivity of the channel. These observa-
tions have led to the conclusion that SOICR is not involved in the disease
mechanism of the RyR2-G230C mutation. However, the cellular impact of
this mutation on SOICR has yet to be determined. To this end, we generated
stable, inducible HEK293 cell lines expressing RyR2-WT and the RyR2-
G230C mutant. We induced SOICR in these cells by elevating extracellular
Ca, and found that the RyR2-G230C mutation markedly enhances the propen-
sity for SOICR. Further, we employed single cell luminal Ca imaging to mon-
itor the luminal Ca dynamics in RyR2-WT- and G230C-expressing cells during
store Ca overload. We found that the G230C mutation significantly reduces the
luminal Ca level at which spontaneous Ca release occurs (i.e. the SOICR
threshold). Therefore, these results and those of previous studies demonstrate
that reduced SOICR threshold is a common defect of CPVT-associated
RyR2 mutations.
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The type 2 ryanodine receptor (RyR2) mediates calcium release from the
sarcoplasmic reticulum of cardiomyocytes. RyR2 mutations found in three
clusters including the amino-terminus are associated with arrhythmogenic car-
diac disease. Arrhythmia-linked mutations are proposed to disrupt interactions
between discrete functional domains within the RyR2 tetramer, resulting in
abnormal channel gating. Recently, we presented evidence that the RyR2
N-terminus self-associates into a tetrameric form, which stabilises the closed
channel conformation.
Here, we report that the arrhythmia-associated L433P mutation affects oligo-
merisation of the RyR2 N-terminus. Tetramerisation ability was tested by
chemical cross-linking experiments of an RyR2 N-terminal fragment (residues
1-906) containing L433P, expressed in HEK293 cells. The mutant fragment
displayed reduced ability for tetramerisation versus wild-type. Two additional
techniques, the yeast two-hybrid system and co-immunoprecipitation assays,
further indicated that the mutant fragment displays reduced self-interaction
and reduced binding to wild-type N-terminus. Notably, dantrolene, a drug
used to treat the clinical symptoms of malignant hyperthermia and whose
target-binding site lies within the RyR N-terminus, was able to partially restore
the tetramer in the L433P mutant.
The effect of the L433P mutation was also investigated in the context of the
full-length channel. We performed sucrose density gradient centrifugation of
CHAPS-solubilised RyR2 to assess the relative stability of tetrameric func-
tional channels. We found that wild-type RyR2 remains a tetramer consistent
with an intact functional channel, whereas a substantial proportion of RyR2/
L433P channels is dissociated into monomers.
Our findings suggest that disruption of inter-subunit interactions within the
N-terminus of mutant RyR2 might contribute to the mechanism by which
some of the arrhythmia-associated mutations result in RyR2 channel
dysfunction.
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The sarcoplasmic reticulum (SR) of cardiomyocytes contains the cardiac
ryanodine receptor (RyR2) - a calcium release channel that plays a pivotal
role in mediating the SR calcium release essential for cardiac excitation-
contraction coupling. Discrete clusters of point mutations, that may comprise
important regulatory regions within RyR2, have been associated with catechol-
aminergic polymorphic ventricular tachycardia (CPVT). In response to a phys-
iological trigger, RyR2 bearing CPVT mutations are believed to cause diastolic
calcium leak, which can result in a fatal arrhythmia. A RyR2 central domain,
which encompasses both a CPVT-associated region and a predicted ATP
binding motif, has been expressed as a soluble recombinant protein. The
wild-type protein was compared with three constructs each containing a differ-
ent CPVT mutation (P2328S, F2331S and N2368I). ATP is a physiological
activator of RyR2 activity and caffeine has a similar effect. Fluorescence
spectroscopy was used to record changes in the intrinsic fluorescence of the
single tryptophan residue present within the expressed domain, and we found
